Exploring <i>Cryptococcus neoformans</i> CYP51 and Its Cognate Reductase as a Drug Target
<i>Cryptococcus</i> remains a leading cause of invasive fungal infections in immunocompromised people. Resistance to azole drugs has imposed a further challenge to the effective treatment of such infections. In this study, the functional expression of full-length hexahistidine-tagged <...
Main Authors: | Yasmeen N. Ruma, Mikhail V. Keniya, Brian C. Monk |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Journal of Fungi |
Subjects: | |
Online Access: | https://www.mdpi.com/2309-608X/8/12/1256 |
Similar Items
-
Environmental Status of <i>Cryptococcus neoformans</i> and <i>Cryptococcus gattii</i> in Colombia
by: Briggith-Nathalia Serna-Espinosa, et al.
Published: (2021-05-01) -
Ergosterol Is Critical for Sporogenesis in <i>Cryptococcus neoformans</i>
by: Amber R. Matha, et al.
Published: (2024-01-01) -
Development of a Real-Time PCR Assay to Identify and Distinguish between <i>Cryptococcus neoformans</i> and <i>Cryptococcus gattii</i> Species Complexes
by: Enoch Tay, et al.
Published: (2022-04-01) -
The Antifungal Effects of Berberine and Its Proposed Mechanism of Action Through CYP51 Inhibition, as Predicted by Molecular Docking and Binding Analysis
by: Chao-Wei Zhang, et al.
Published: (2024-10-01) -
Roles of Different Signaling Pathways in <i>Cryptococcus neoformans</i> Virulence
by: Fawad Mahmood, et al.
Published: (2024-11-01)